AzTrials
AzTrials

BehaviorCABxtimeNCT06705179

Can Computational Measures of Task Performance Predict Psychiatric Symptoms and Changes in Symptom Severity Across Time

A study testing Behavioral task performance in people with Behavior and Depressive Disorder, run by California Institute of Technology at 2 sites in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study investigates the computational mechanisms associated with psychiatric disease dimensions. The study will characterize the relationship between computational parameter estimates of task performance and psychiatric symptoms and diagnoses with a longitudinal approach over a 12 month interval. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Behavior, Depressive Disorder, Anxiety Disorders
What is being tested?
Behavioral task performance
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,100 participants
Where
2 sitesUnited States
Study dates
1 Jan 2025to 31 Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age range of 18 to 65.
  • Not currently having a psychiatric diagnosis determined after psychiatric evaluation by Drs. Tadayon-Nejad and Wei (both are board certified psychiatrists).
  • Ability to understand and perform experimental tasks, i.e. basic ability to communicate and comprehend tasks.
  • Ability to give informed consent.
  • Age range of 18 to 65.
  • Psychiatric diagnosis of any type of depressive disorders, any type of anxiety disorders or obsessive-compulsive disorder.
Show all 10Show fewer
  • Primary or comorbid bipolar disorders are allowed but only if not in the acute manic phase.
  • Comorbidity with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are allowed.
  • Ability to understand and perform experimental tasks, i.e. basic ability to communicate and comprehend tasks.
  • Ability to give informed consent.

Who cannot join

  • Prior history and or current diagnosis of neurological disease.
  • Prior history and or current diagnosis of neurological disease.
  • History or current diagnosis of psychotic disorders.
  • Currently active substance use disorder.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

John P O'Doherty, D.Phil contact

626-395-5981

jdoherty@hss.caltech.edu

United States2 sites
  • UCLA Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles

    Los Angeles, California, 90095

    Reza Tadayon-nejad, MD PhD, 310-206-6389, RTadayonNejad@mednet.ucla.edu

  • California Insitute of Technology

    Pasadena, California, 91125

    John O'Doherty, D Phil, 626-395-5981, jdoherty@hss.caltech.edu

Other trials in United States

About this study

Official title: Leveraging Computationally Derived Measures of Individual Differences in Learning and Decision-making to Predict Psychiatric Diagnosis, Symptoms and Changes in Symptom Severity Across Time

This study investigates the computational mechanisms associated with psychiatric disease dimensions. The study will characterize the relationship between computational parameter estimates of task performance and psychiatric symptoms and diagnoses with a longitudinal approach over a 12 month interval. Participants will be healthy participants recruited through Prolific an on-line crowdsourcing service, and psychiatric patients and healthy participants recruited via UCLA Psychiatry Clinics and UCLA's STAND Program

Read the detailed description

The goal of computational psychiatry is to gain knowledge about underlying neurocomputational processes that underpin psychiatric disorders and to leverage this knowledge for improving diagnosis and treatment. A key step toward achieving this goal is to develop measures of individual differences in computations obtained from a single individual that are reliable, robust and meaningfully relevant to psychiatric dysfunction. In order to attain these objectives, it is essential we substantiate relationships between candidate computational mechanisms and diagnostic categories, symptom dimensions and treatment outcomes. In the present study, a computational assessment task battery (CAB) will be utilized that is designed to measure individual differences across a multidimensional array of computational processes. The study aims to separate three different variance components contributing to variability in computational parameter estimation: occasion-related variance due to incidental day to day changes in task performance, state-dependent variance that is related to meaningful variation across time in the underlying computations within an individual, and trait-related differences pertaining to stable individual differences in computations across individuals. To accomplish this, repeated assessments will be implemented using this battery across a 1-year interval within an on-line sample, and use hierarchical Bayesian modeling to separate the effect of occasion, state and trait-related variance on these parameter estimates. These variance components will then be related to diagnostic categories, symptom dimensions and symptom severity measures in a diverse cohort of psychiatric patients (mostly with depression, anxiety and OCD) recruited in Southern California. Finally, the relationship will be tracked between the computational parameter estimates and changes in symptoms across time in a subset of these patients. This study promises to significantly advance understanding of how to reliably extract diagnostically relevant computationally-derived measures of cognitive phenotypes that could eventually be migrated to the clinic.

Being tested
Behavioral task performance
Keywords
Computational Psychiatry, Behavioral task battery
Medical subject headings
Behavior, Depressive Disorder, Anxiety Disorders, Obsessive-Compulsive Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral task performanceBehavioural

    Measures of performance on behavioral tasks

Study groups in NCT06705179
Study groupRoleWhat they receive
Behavioral task batteryOtherNot described
Receives: Behavioral: Behavioral task performance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in DASS depression scale scores

    Changes in computational parameter estimates related to gain/loss learning, reward/effort tradeoff and reward/predation risk tradeoffs will correlate with changes in DASS depression scale scores across time.

    Measured: 12 months

  2. Changes in DASS anxiety scale scores

    Changes in computational parameter estimates related to novelty driven exploration and reward/predation risk tradeoffs will be correlated with changes in DASS anxiety scale scores

    Measured: 12 months

  3. Changes in OCI-R scores

    Changes in computational parameter estimates related to the balance between model-based vs model-free reinforcement-learning will be correlated with changes in OCI-R symptoms across time.

    Measured: 12 months

  4. OCI-R scores

    Computational parameter estimates related to the balance between model-based vs model-free reinforcement-learning will be correlated with OCI-R scores.

    Measured: 12 months

  5. DASS depression scale scores

    Computational parameter estimates related to gain/loss learning, reward/effort tradeoff and reward/predation risk tradeoffs will correlate with DASS depression scale scores.

    Measured: 12 months

  6. DASS anxiety scale scores

    Computational parameter estimates related to novelty driven exploration and reward/predation risk tradeoffs will be correlated with DASS anxiety scale scores

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2024
  2. Study start1 Jan 2025 (estimated)
  3. Primary completion31 Dec 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
1,100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06705179
Sponsor's protocol ID
1R01MH138895
Acronym
CABxtime
Status last verified
Nov 2024
First submitted
18 Nov 2024
Last updated
26 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual task performance data will be provided (trial data) and individual questionnaire scores will be available.

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral task performance in people with Behavior and Depressive Disorder, run by California Institute of Technology at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact John P O'Doherty, D.Phil (626-395-5981, jdoherty@hss.caltech.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in DASS depression scale scores (time frame: 12 months). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in